CIR May Reopen File On Human Umbilical Extract With Products In Pipeline
This article was originally published in The Rose Sheet
Executive SummaryA Las Vegas company's intent to use human umbilical extract in skin-care products may prompt the Cosmetic Ingredient Review Expert Panel to reopen a safety assessment of the ingredient.
You may also be interested in...
Novo Solutions MD claims that its NovoSerum, derived from purified human umbilical cord blood, will “stop, slow and reverse skin damage” in 30 days.